September 10th 2025
Nerandomilast, with a PDUFA date of Q4 2025, leads the potential breakthrough therapies, with inhaled treprostinil and admilparant advancing quickly behind.
Drug-Induced and Other Lung Diseases: A Photo Essay
August 11th 2014Drug-induced hypersensitivity pneumonitis, drug-induced organizing pneumonia, radiation-induced lung injury, allergic fungal rhinosinusitis, pulmonary tuberculosis, empyema-this week’s slide show sheds light on several presentations.